Panic, dyspnea, and asthma

Current Opinion in Pulmonary Medicine

Volumn 4, Issue 1, 1998, Pages 40-45

  Smoller, Jordan W ^a   Otto, Michael W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ASTHMA; COGNITIVE THERAPY; COMORBIDITY; DYSPNEA; HUMAN; PANIC; PSYCHOLOGICAL ASPECT; REVIEW;

ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ASTHMA; COGNITIVE THERAPY; COMORBIDITY; DYSPNEA; HUMANS; PANIC DISORDER;

EID: 0031612674     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199801000-00008     Document Type: Article

References (42)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.
2. Dahlem NW, Kinsman RA, Horton DJ: Panic-fear in asthma: requests for as-needed medications in relation to pulmonary function measurements. J Allergy Clin Immunol 1977, 60:295-300.
3. Spinhoven P, van Peski-Oosterbaan A, van der Does A, Willems L, Sterk P: Association of anxiety with perception of hlstamine induced bronchoconstriction in patients with asthma. Thorax 1997, 52:149-152. Report of a study of the effect of anxiety on response to histamine challenge in patients with asthma. The authors found that anxiety was associated with increased dyspnea but also with more accurate perception of airway obstruction.
4. Dirks JF, Jones NF, Kinsman RA: Panic-fear: a personality dimension related to intractability in asthma. Psychosom Med 1977, 39:120-126.
5. Mawhinney H, Spector SL, Heitjan D, Kisman RA, Dirks JF, Pines I: As-needed medication use in asthma: usage patterns and patient characteristics. J Asthma 1993, 30:61-71.
6. Hibbert G, Pilsbury D: Demonstration and treatment of hyperventilation causing asthma. Br J Psychiatry 1988, 153:687-688.
7. Isenberg S, Lehrer P, Hochron S: The effects of suggestion and emotional arousal on pulmonary function in asthma: a review and a hypothesis regarding vagal mediation. Psychosom Med 1992, 54:192-216.
8. Spitzer RL, Williams JBW, Kroenke K, Linzer M, deGruy FV, III, Hahn SR, Brody D, Johnson JG: Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA 1994, 272:1749-1756.
9. Yellowlees PM, Alpers JH, Bowden JJ, Bryant GD, Ruffin RE: Psychiatric morbidity in patients with chronic airflow obstruction. Med J Austr 1987, 146:305-307.
10. Zandbergen J, Bright M, Pols H, Fernandez I, de Loof C, Griez EJL: Higher lifetime prevalence of respiratory diseases in panic disorder? Am J Psychiatry 1991, 148:1583-1585.
11. Spinhoven P, Ros M, Westgeest A, Van der Does AJW: The prevalence of respiratory disorders in panic disorder, major depressive disorder and V-code patients. Behav Res Ther 1994, 32:647-649.
12. Verburg K, Griez E, Meijer J, Pols H: Respiratory disorders as a possible predisposing factor for panic disorder. J Affect Disord 1995, 33:129-134.
13. Pollach MH, Kradin R, Otto MW, Worthington J, Gould R, Sabatino SA, Rosenbaum J: Prevalence of panic disorder in patients referred for pulmonary function testing at a major medical center. Am J Psychiatry 1996, 153:110-113.
14. Perna G, Bertani A, Politi E, Colombo G, Bellodi L: Asthma and panic attacks. Biol Psychiatry 1997, 42:625-630. Examines the prevalence of panic disorder and panic attacks in a sample of 51 patients with asthma. The finding that the onset of asthma almost always preceded the onset of panic supports the hypothesis that asthma may be a risk factor for the development of panic disorder.
15. Bussing R, Burket R, Kelleher E: Prevalence of anxiety disorders in a clinic-based sample of pediatric asthma patients. Psychosomatics 1996, 37:108-115.
16. Van Peski-Osterbaan A, Spinhoven P, Van der Does A, Willems L, Sterk P: Is there a specific relationship between asthma and panic disorder? Behav Res Ther 1996, 34:333-340.
17. Shavitt RG, Gentil V, Mandetta R: The association of panic/agoraphobia and asthma: contributing factors and clinical implications. Gen Hosp Psychiatry 1992, 14:420-423.
18. Schmaling K, Bell J: Asthma and panic disorder. Arch Fam Med 1997, 6:20-23. A survey comparing patients with asthma with patients with panic disorder on symptom profiles. The diagnostic dilemma of distinguishing an asthma attack from a panic attack is addressed by identifying symptoms from the Asthma Symptom Checklist that were significantly more characteristic of an asthma attack.
19. Smoller JW, Pollack MH, Otto MW, Rosenbaum JF, Kradin R: Panic-anxiety, dyspnea and respiratory disease: theoretical and clinical considerations. Am J Respir Crit Care Med 1996, 154:6-17. A comprehensive review of the relationship between anxiety, dyspnea, and respiratory illness. The epidemiology of anxiety in chronic obstructive pulmonary disease, asthma, sleep apnea, and other pulmonary disorders is discussed. Issues in the diagnosis and management of anxiety in patients with respiratory illness are reviewed, including the use of psychotrapic medications and cognitive-behavioral therapy.
20. Gardner W: The pathophysiology of hyperventilation disorders. Chest 1996, 109:516-534.
21. Garssen B, Buikhuisen M, van Dyck R: Hyperventilation and panic attacks. Am J Psychiatry 1996, 153:513-518.
22. Klein DF: False suffocation alarms, spontaneous panics, and related conditions: an integrative hypothesis. Arch Gen Psychiatry 1993, 50:306-317.
23. Papp LA, Klein DF, Gorman JM: Carbon dioxide hypersensitivity, hyperventilation and panic disorder. Am J Psychiatry 1993, 150:1149-1157.
24. Papp LA, Gorman JM: Respiratory neurobiology of panic. In Panic Disorder: Clinical, Biological, and Treatment Aspects. Edited by Asnis GM, van Praag HM. New York: John Wiley & Sons; 1995:255-275.
25. McNally RJ: Panic Disorder: A Critical Analysis. New York: Guilford Press; 1994.
26. Carr RE, Lehrer PM, Rausch LL, Hochron SM: Anxiety sensitivity and panic attacks in an asthmatic population. Behav Res Ther 1994, 32:411-418.
27. Porzelius J, Vest M, Nochomovitz M: Respiratory function, cognitions, and panic in chronic obstructive pulmonary patients. Behav Res Ther 1992, 30:75-77.
28. Joseph K, Blais L, Ernst P, Suissa S: Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquilizers. BMJ 1996, 312:79-83.
29. Joseph K: Asthma mortality and antipsychotic or sedative use: what is the link? Drug Saf 1997, 16:351-354. The use of antipsychotic and sedative medications has been associated with risk of fatal or near-fatal asthma. Both causal and noncausal mechanisms for this association are discussed.
30. Papp LA, Weiss JR, Greenberg HE, Rifkin A, Scharf SM, Gorman JM, Klein DF: Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders [letter]. Am J Psychiatry 1995, 152:1531.
31. Smoller JW, Pollack MH, Systrom D, Kradin R: Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics, in press, 1998.
32. van den Brekel A, Harrington L: Toxic effects of theophylline caused by fluvoxamine. Can Med Assoc J 1994, 151:1289-1290.
33. Dudley DL, Glaser EM, Jorgenson BN, Logan DL: Psychosocial concomitants to rehabilitation in chronic obstructive pulmonary disease: 3: dealing with psychiatric disease (as distinguished from psychosocial or psychophysiological problems). Chest 1980, 77:677-684.
34. Alpert J, Bernstein JG, Rosenbaum J: Psychopharmacologic issues in the medical setting. In Massachusetts General Hospital Handbook of General Hospital Psychiatry, edn 4. Edited by Cassem N, Stern T, Rosenbaum J, Jellinek M. St. Louis: Mosby Year Book; 1997:249-303. Provides a review of principles of psychopharmacologic practice with specific attention to drug-drug interactions.
35. Kiev A, Domantay AG: A study of buspirone coprescribed with bronchodilators in 82 anxious ambulatory patients. J Asthma 1988, 25:281-284.
36. Denault M, Yernault JC, Coster AD: Double-blind comparison of the respiratory effects of parenteral lorazepam and diazepam in patients with chronic obstructive lung disease. Curr Med Res Opin 1975, 2:611-615.
37. Tandon M: Effect on respiration of diazepam, chlorpromazine and haloperidol in patients with chronic airways obstruction. Aust N Z J Med 1976, 6:561-565.
38. Otto M, Gould R: Maximizing treatment outcome for panic disorder: cognitive-behavioral strategies. In Challenges in Clinical Practice. Edited by Pollack M, Otto M, Rosenbaum J. New York: Guilford Press; 1996:113-140. This chapter discusses the cognitive-behavioral model of panic disorder and its application to the treatment of panic disorder. Other chapters present guidelines for both pharmacologic and psychosocial treatment of panic disorder and other anxiety disorders.
39. Gould R, Otto M, Pollack M: A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev 1995, 15:819-844.
40. Swinson R, Soulios C, Cox B, Kuch K: Brief treatment of emergency room patients with panic attacks. Am J Psychiatry 1992, 149:944-946.
41. Freedberg PD, Hoffman LA, Light WC, Kreps MK: Effect of progressive muscle relaxation on the objective symptoms and subjective responses associated with asthma. Heart Lung 1987, 16:24-30.
42. Lehrer PM, Sargunaraj D, Hochron S: Psychological approaches to the treatment of asthma. J Consult Clin Psychol 1992, 60:639-643.